Cannasoul is an Israeli cannabis drug-discovery company developing therapeutics derived from natural compounds.
Cannasoul's proprietary analytical platform, data-driven approach, knowhow, and clinical trial framework support active compound identification and development, from botanical extract through clinical approved formulation.
Cannasoul has analyzed over 100 cannabinoids and 100 terpenes. The company's subsidiaries include MyPlant Bio, Psyga Bio, Nidra Logic, and CaVnox.
Cumulative Funding Raised Over Time ($)
Employees Over Time
Cannasoul Analytics Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Nov 2, 2025
www.globenewswire.com
InterCure and Cannasoul Sign Strategic Investment and Collaboration Agreements to Advance Cannabis Science and Pharmaceutical Innovation
#Partners #Acquisition
Nov 2, 2023
www.tipranks.com
Synaptogenix Acquires Significant Stake in Cannasoul Analtyics Ltd. Co-founded by The Technion - Israel Institute of Technology - TipRanks.com
#Partners #Acquisition #Investment
Apr 22, 2020
www.prnewswire.com
Eybna and CannaSoul, Top Cannabis R&D Firms, Join Forces to Prove a Proprietary Terpene Formulation for Treating Viral Infections via Modulation of Cytokine Storm
#Partners
Mar 28, 2019
plantsresearchmedicine.com
Kensana Health Enters Joint Venture With Cannasoul Analytics
InterCure and Cannasoul Sign Strategic Investment and Collaboration Agreements to Advance Cannabis Science and Pharmaceutical Innovation
#Partners #Acquisition
Nov 2, 2023
www.tipranks.com
Synaptogenix Acquires Significant Stake in Cannasoul Analtyics Ltd. Co-founded by The Technion - Israel Institute of Technology - TipRanks.com
#Partners #Acquisition #Investment
Apr 22, 2020
www.prnewswire.com
Eybna and CannaSoul, Top Cannabis R&D Firms, Join Forces to Prove a Proprietary Terpene Formulation for Treating Viral Infections via Modulation of Cytokine Storm
#Partners
Mar 28, 2019
plantsresearchmedicine.com
Kensana Health Enters Joint Venture With Cannasoul Analytics